Samsung Electronics launched the Galaxy Ring 2 at a product event in Seoul on September 2, 2026, featuring continuous blood pressure monitoring, electrocardiogram capabilities, and a 14-day battery life that triples the performance of the original Galaxy Ring. ## Next-Generation Health Wearable Sets New Industry Standard The device, priced at 399 dollars, incorporates Samsung proprietary BioActive Sensor 2 chip, which the company claims achieves medical-grade accuracy for blood pressure readings within 3 mmHg of traditional cuff measurements. The sensor uses photoplethysmography combined with bioimpedance analysis to deliver continuous cardiovascular monitoring without requiring user calibration. "Galaxy Ring 2 represents our vision of invisible health technology," President of Samsung Electronics MX Division T.M. Roh said at the launch event. "Wearables should enhance health outcomes without demanding attention from the wearer." The 14-day battery life represents a significant engineering achievement. The original Galaxy Ring lasted approximately 5 days, while Apple competitors offer 3 to 7 days depending on usage patterns. Samsung achieved the improvement through a new 18-millimeter lithium-silicon battery and a custom low-power co-processor that handles sensor data without activating the main chipset. ## Technical Specifications and Health Features Samsung medical technology division confirmed that the Galaxy Ring 2 has received FDA clearance for its blood pressure monitoring function and CE marking for the European market. The device also monitors blood oxygen saturation, skin temperature, sleep stages, and heart rate variability with accuracy comparable to clinical-grade pulse oximeters. Dr. Yong-in Kim, head of Samsung digital health research laboratory, presented clinical validation data from a 5,000-patient study conducted across Samsung Medical Center and Seoul National University Hospital. "The correlation coefficient between Galaxy Ring 2 blood pressure readings and invasive arterial measurements was 0.94, exceeding the 0.90 threshold required for medical device classification," Dr. Kim reported. The ring also introduces atrial fibrillation detection using a single-lead ECG sensor integrated into the interior surface. Samsung claims the AFib detection algorithm achieves 97.3 percent sensitivity and 95.8 percent specificity, validated across a dataset of 120,000 cardiac recordings. The device alerts users to irregular heart rhythms and can automatically share reports with designated physicians through Samsung Health. ## Market Competition and Pricing Strategy Apple is expected to announce its own ring-based wearable at its September 2026 product event, creating direct competition in a segment that barely existed two years ago. IDC projects that smart ring shipments will reach 42 million units in 2026, up from 18 million in 2025. Samsung pricing strategy positions the Galaxy Ring 2 at 100 dollars below Apple rumored price point, while offering superior battery life and blood pressure monitoring that Apple device is not expected to include at launch. Canalys analyst Nicole Peng noted that Samsung health sensor expertise gives it a meaningful advantage. "Samsung has been investing in miniaturized medical sensors for over a decade," Peng said. "This expertise is difficult for competitors to replicate quickly." The Galaxy Ring 2 will be available in titanium black, silver, and gold finishes, with sizing kits shipping from Samsung website starting September 15. The device is compatible with all Android smartphones running Samsung Health 7.0 or later, though full feature integration requires pairing with a Samsung Galaxy smartphone.